<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02914015</url>
  </required_header>
  <id_info>
    <org_study_id>CXL4</org_study_id>
    <nct_id>NCT02914015</nct_id>
  </id_info>
  <brief_title>Ultrasound-guided Continous Quadratus Lumborum Block: Effect on Acute Pain and Quality of Recovery After Hepatic Surgery With Right Subcostal Incision</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cui Xulei</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, randomized study, control study aims to compare the analgesic effect,
      opioids consumption, quality of recovery, length of hospital stay and et al. between
      unilateral continuous quadratus lumborum block (QLB) and intravenous patient-controlled
      analgesia (IPCA) alone in patients undergoing hepatectomy with right J-shape subcostal
      incision.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative morphine consumption</measure>
    <time_frame>at 24 postoperative hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The pain scores determined by the numeric rating scale (NRS, 0-10)</measure>
    <time_frame>At 0, 2,4, 8, 12, 24 ,48,72 hours and 7 day after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea and Vomiting score</measure>
    <time_frame>At 0, 2,4, 8, 12, 24 and 48 hours after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pruritus score</measure>
    <time_frame>At 0, 2,4, 8, 12, 24 and 48 hours after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ambulation time</measure>
    <time_frame>within the 7 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of recovery of bowl movement</measure>
    <time_frame>within the 7 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of recovery</measure>
    <time_frame>3 days and 7 days after surgery</time_frame>
    <description>use the self-assessment 11 item QoR scale to assess the patient's recovery quality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with anesthesia</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>use the Chinese version Bauer questionnaire to assess the patient satisfaction with anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative hospital length of stay</measure>
    <time_frame>Up to 6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Hepatectomy</condition>
  <condition>Analgesia</condition>
  <condition>Nerve Block</condition>
  <arm_group>
    <arm_group_label>Continuous QLB+postoperative IPCA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single-injection of QLB (quadratus lumborum block) is given preoperatively followed with continuous infusion+ postoperative IPCA (intravenous patient control analgesia)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IPCA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Postoperative IPCA (intravenous patient control analgesia) is given alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continous QLB (quadratus lumborum block)</intervention_name>
    <arm_group_label>Continuous QLB+postoperative IPCA</arm_group_label>
    <other_name>Inject local anesthetics in between quadratus lumborum and psoas major muscle with catheter insertion and continuous local infusion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Philip CX50 Ultrasound Scanner</intervention_name>
    <description>The curved (C1-5) probe of Philip CX 50 Ultrasound Scanner is used for scan</description>
    <arm_group_label>Continuous QLB+postoperative IPCA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PAJUNK Contiplex S Catheter</intervention_name>
    <arm_group_label>Continuous QLB+postoperative IPCA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>0.6ml/kg 0.5% ropivacaine with 1:200,000 adrenaline given immediately after the correct position of the tip of the needle has been verified.
followed with 0.2% ropivacaine infusion at a rate of 0.125ml/kg/h given through the catheter inserted in between the quadratus lumborum muscle and psoas major muscle.</description>
    <arm_group_label>Continuous QLB+postoperative IPCA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine given as IPCA</intervention_name>
    <description>Bolus: 1-2mg, lock time: 10min, 1h limitation: 5-10mg. without background infusion.</description>
    <arm_group_label>Continuous QLB+postoperative IPCA</arm_group_label>
    <arm_group_label>IPCA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-70 yrs

          -  American Society of Anesthesiologists physical statusⅠ-Ⅲ

          -  Undergo hepatectomy with right J-shape subcostal incision

          -  Informed consent

        Exclusion Criteria:

          -  A known allergy to the drugs being used

          -  Coagulopathy, on anticoagulants

          -  Analgesics intake, history of substance abuse

          -  Participating in the investigation of another experimental agent

          -  Inability to properly describe postoperative pain to investigators (eg, language
             barrier, neuropsychiatric disorder)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuguang Huang, MD.</last_name>
    <role>Study Chair</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xulei CUI</last_name>
    <phone>+8613717739381</phone>
    <email>cui.xulei@aliyun.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xulei CUI</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xulei CUI, MD</last_name>
      <phone>08613717739381</phone>
      <email>cui.xulei@aliyun.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2016</study_first_submitted>
  <study_first_submitted_qc>September 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2016</study_first_posted>
  <last_update_submitted>September 19, 2017</last_update_submitted>
  <last_update_submitted_qc>September 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Peking Union Medical College Hospital</investigator_affiliation>
    <investigator_full_name>Cui Xulei</investigator_full_name>
    <investigator_title>Attending Physician</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

